TRAX insider trading — First Tracks Biotherapeutics, Inc.
Over the last 90 days, insiders at First Tracks Biotherapeutics, Inc. (TRAX) made 0 open-market purchases worth $0 and 1 open-market sale worth $1.76M, making them net sellers by $1.76M. The largest sale was by Ware J. Anthony (Director), who sold 39,265 shares for $1.76M on Sep 2, 2026.
Updated Oct 16, 2026.
Recent TRAX insider transactions
Every Form 4 filed by First Tracks Biotherapeutics, Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Orwin John A | Director | M · Option exercise | Direct | 1,300 | — | — | Form 4 |
| Sep 2, 2026 | Ware J. Anthony | Director | M · Option exercise | Direct | 39,265 | $5.74 | $225K | Form 4 |
| Sep 2, 2026 | Ware J. Anthony | Director | S · Sale | Direct | 39,265 | $44.78 | $1.76M | Form 4 |
TRAX insider trading FAQ
Are insiders buying TRAX stock?
Not on the open market. In the last 90 days, First Tracks Biotherapeutics, Inc. insiders made no open-market purchases, and 1 open-market sale totaling $1.76M. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading TRAX?
Recent sellers: Ware J. Anthony.
Where does TRAX insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.